| Literature DB >> 16987271 |
J M Martín1, M J Nicolau, A Galán, A Ferrández-Izquierdo, A M Ferrer, E Jordá.
Abstract
CD4+/CD56+ hematodermic neoplasm, formerly known as blastic NK cell lymphoma, is an aggressive and rare preculsor hematologic neoplasm recently recognized by the WHO-EORTC classification consensus for cutaneous lymphomas. The neoplasm tends to affect elderly patients, who usually present with skin lesions but often have a disseminated disease, including bone marrow involvement. Although the lesions are composed of cells with a lymphoblast-like morphology and an NK-cell phenotype, exhibiting a CD4+, CD56+ positive immunophenotype, recent studies support a relationship to plasmacytoid dendritic cells. Because of the rarity of this disease, we describe two patients suffering a CD4+/CD56+ hematodermic neoplasm.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16987271 DOI: 10.1111/j.1468-3083.2006.01743.x
Source DB: PubMed Journal: J Eur Acad Dermatol Venereol ISSN: 0926-9959 Impact factor: 6.166